Search hospitals > California > Whittier
Innovative Clinical Research Institute
Claim this profileWhittier, California 90603
Global Leader in Lung Cancer
Global Leader in Non-Small Cell Lung Cancer
Conducts research for Breast Cancer
Conducts research for Pancreatic Cancer
Conducts research for Cancer
123 reported clinical trials
9 medical researchers
Summary
Innovative Clinical Research Institute is a medical facility located in Whittier, California. This center is recognized for care of Lung Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Pancreatic Cancer, Cancer and other specialties. Innovative Clinical Research Institute is involved with conducting 123 clinical trials across 123 conditions. There are 9 research doctors associated with this hospital, such as Omkar S Marathe, Richy Agajanian, MD, Paul La Porte, and Amitabha Mazumder.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
PD-L1 positive
2Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
PD-L1 positive
Top PIs
Omkar S MaratheThe Oncology Institute of Hope and Innovation4 years of reported clinical research
Studies Colorectal Cancer
Studies Lung Cancer
18 reported clinical trials
31 drugs studied
Richy Agajanian, MDInnovative Clinical Research Institute9 years of reported clinical research
Studies Lymphoma
Studies Non-Small Cell Lung Cancer
13 reported clinical trials
20 drugs studied
Paul La PorteGSK Investigational Site4 years of reported clinical research
Studies Lung Cancer
Studies Breast Cancer
10 reported clinical trials
18 drugs studied
Amitabha MazumderThe Oncology Institute of Hope and Innovation6 years of reported clinical research
Studies Relapse
Studies Multiple Myeloma
9 reported clinical trials
19 drugs studied
Clinical Trials running at Innovative Clinical Research Institute
Lung Cancer
Chronic Lymphocytic Leukemia
Follicular Lymphoma
Myelofibrosis
B-Cell Leukemia
Lymphoma
Cancer
Pancreatic Cancer
Breast Cancer
Multiple Myeloma
ABP 234 vs Keytruda
for Lung Cancer
The primary objective of this study is to compare the efficacy of ABP 234 with the pembrolizumab reference product (Keytruda®).
Recruiting2 awards Phase 36 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This trial is testing two new drugs, zimberelimab and domvanalimab, combined with chemotherapy for patients with advanced lung cancer that has spread and lacks specific genetic targets. These drugs help the immune system better recognize and attack cancer cells. The goal is to see if this combination improves survival compared to another drug, pembrolizumab, with chemotherapy.
Recruiting2 awards Phase 38 criteria
DB-1303
for Solid Cancers
This trial is testing a new drug called DB-1303 to see if it is safe for patients with advanced solid tumors that express HER2. The study will begin with lower doses and increase them over time to find the highest dose that patients can handle. This helps determine the best dose for future studies.
Recruiting1 award Phase 1 & 22 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Innovative Clinical Research Institute?
Innovative Clinical Research Institute is a medical facility located in Whittier, California. This center is recognized for care of Lung Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Pancreatic Cancer, Cancer and other specialties. Innovative Clinical Research Institute is involved with conducting 123 clinical trials across 123 conditions. There are 9 research doctors associated with this hospital, such as Omkar S Marathe, Richy Agajanian, MD, Paul La Porte, and Amitabha Mazumder.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.